VIVA Physicians, a leader in education and advocacy, convened a diverse coalition of stakeholders to address timely issues in peripheral arterial disease: care, reimbursement, and industry innovation. Stakeholders at the Vascular Leader’s Forum in Washington, DC, included representatives from major medical societies, US regulatory agencies, and representatives from the medical device industry, to explore the complexities of treating patients with carotid artery disease and ways to increase access to care.
The resulting paper, “Carotid Artery Stenting in Asymptomatic Carotid Artery Stenosis,” authored by VIVA board members Joshua A. Beckman, MD; Sean P. Lyden, MD; and founding board members, Tony S. Das, MD; and Gary M. Ansel, MD, was published in the February 2020 issue of the Journal of the American College of Cardiology (JACC). The paper details how recent clinical trials have advanced the evidence supporting carotid artery stenting in asymptomatic internal carotid artery stenosis and calls for reimbursement for use in appropriate patients.
The paper is available here, along with an audio summary of the content: http://www.onlinejacc.org/content/75/6/648
VIVA Physicians is a not-for-profit organization dedicated to PAD education, advocacy and research since 2003.
For questions contact firstname.lastname@example.org.